LY-M003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY-M003, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease [EARLY_Phase 1]